2002
DOI: 10.1097/00004872-200205000-00004
|View full text |Cite
|
Sign up to set email alerts
|

Angiotensin I, angiotensin II and their biologically active peptides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2003
2003
2013
2013

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 18 publications
0
17
0
Order By: Relevance
“…A possible beneficial effect could be induced by the direct renin inhibitor (DRI) drug, aliskiren, in relation to vascular reactivity in cases of hypercholesterolemia and associated oxidative stress. Yet, it is not well defined if the vascular protection induced by drugs acting on RAAS is due to the resulting inhibition of Ang II production, the inhibition of the effect of Ang II on Angiotensin receptors type 2 (AT2) or the accompanied availability of other bioactive angiotensin peptides as Ang III, Ang IV, and Ang1-7 that affect receptors other than Angiotensin receptors type 1 (AT1) [4][5][6]. Pharmacological researches, done on aliskiren, could provide suggested evidence about its possible action on different types of angiotensin in the pathogenesis of atherosclerosis.…”
Section: Introductionmentioning
confidence: 99%
“…A possible beneficial effect could be induced by the direct renin inhibitor (DRI) drug, aliskiren, in relation to vascular reactivity in cases of hypercholesterolemia and associated oxidative stress. Yet, it is not well defined if the vascular protection induced by drugs acting on RAAS is due to the resulting inhibition of Ang II production, the inhibition of the effect of Ang II on Angiotensin receptors type 2 (AT2) or the accompanied availability of other bioactive angiotensin peptides as Ang III, Ang IV, and Ang1-7 that affect receptors other than Angiotensin receptors type 1 (AT1) [4][5][6]. Pharmacological researches, done on aliskiren, could provide suggested evidence about its possible action on different types of angiotensin in the pathogenesis of atherosclerosis.…”
Section: Introductionmentioning
confidence: 99%
“…Angiotensin (Ang) II and other active peptides of the reninangiotensin system, such as Ang IV [Ang- (3)(4)(5)(6)(7)(8)] and Ang- (1)(2)(3)(4)(5)(6)(7), are mostly known as regulators in the cardiovascular system. 1 However, recent studies have shown that AngII and Ang-(1-7) also have regulatory effect on tissue regeneration, cellular proliferation and growth factor release.…”
Section: Introductionmentioning
confidence: 99%
“…1 However, recent studies have shown that AngII and Ang-(1-7) also have regulatory effect on tissue regeneration, cellular proliferation and growth factor release. 2,3 In vivo studies have shown that AngII and Ang-(1-7) increased hematopoietic recovery after myelosuppression and progenitor engraftment.…”
Section: Introductionmentioning
confidence: 99%
“…Besides AngII, other Ang peptides, such as AngIV [Ang-(3-8)] and Ang-(1-7) may also have important biological activities (Figure 1). 124 In vascular smooth muscle cells, Ang IV binds to the AT4 receptor, activates NF-κB and increases MCP-1. 125 In the kidney Ang-(1-7) has AT1/AT2-independent inflammatory properties: it binds to the Mas receptor, activates NF-κB and promotes the secretion of NF-κB-dependent proinflammatory molecules.…”
Section: Renin-angiotensin System (Ras)mentioning
confidence: 99%